Montemore LT-Antagonist

Montelukast sodium, is a selective and orally active leukotriene receptor antagonist that inhibits the cysteinyl leukotriene CysLT1 receptor, which is widely used for the prophylaxis and chronic treatment of asthma.

Montemore

Montemore Montelukast as sodium 10mg

  • Dosage and administration

    Adults

    Aged 15 years and older

    Indication Dose Dose
     Asthma 10 mg Once daily in evening
    Symptomatic relief of seasonal allergic rhinitis 10 mg Once daily in evening
    Exercise-induced bronchoconstriction 10 mg At least 2 hours before exercise
    Seasonal allergic rhinitis (SAR) 10 mg Once daily in evening

    Paediatric

    Aged 6 to 14 years

    Indication Dose Dose
     Asthma 5 mg Once daily in evening
    Symptomatic relief of seasonal allergic rhinitis 5 mg Once daily in evening
    Exercise-induced bronchoconstriction 5 mg At least 2 hours before exercise
    Seasonal allergic rhinitis (SAR) 5 mg Once daily in evening
  • Contraindications

    Hypersensitivity to any component of montelukast.